Beyond exposure

A healthy broadening of posttraumatic stress disorder treatment options: Commentary on Rubenstein et al. (2024)

Bibliographic Data

ID13349403
AuthorsLisa M Najavits (0000-0002-3117-8069, UMass Memorial Medical Center, corresponding author)
Year2024
Volume79
Issue3
Pages347-349
Publication date2024-04-01
Peer ReviewedYes
Open AccessNo
TypeARTICLE
VenueAmerican Psychologist (JOURNAL)
Journal identifiersISSN: 0003-066X • E-ISSN: 1935-990X
PublisherAmerican Psychological Association (PUBLISHER • US)
DOI10.1037/amp0001233
PMID38635197
OpenAlexW4394920455
LanguageEN
Citations received1

This commentary on Rubenstein et al. (2024) applauds their sensitive historical exploration of exposure therapy for posttraumatic stress disorder (PTSD) and balanced review of the strengths and weaknesses of that approach. I offer five points to expand on their contribution. (a) Stringent exposure therapy workforce requirements limit scalability, thus restricting access for the large number of patients in need of PTSD treatment. (b) There are additional non-trauma-focused approaches that show efficacy for PTSD. (c) Results of exposure therapy trials should be interpreted in light of how much the study designs align with real-world conditions. (d) Some surprising results from the subfield of PTSD/substance use disorder could suggest new treatment options. (e) There is a need for stronger reporting of clinical worsening (iatrogenesis) outside of clinical trials. (PsycInfo Database Record (c) 2024 APA, all rights reserved)

Clinical trial · MEDLINE · Political science · Posttraumatic stress · Psychiatry · Psychotherapist · PsycINFO · Workforce · Clinical Psychology · Internal Medicine · Medicine · Posttraumatic Stress Disorder Research · Psychology

Tools

Open DOI